Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract

Details for Australian Patent Application No. 2004237401 (hide)

International Classifications

Event Publications

24 November 2005 PCT application entered the National Phase

PCT publication WO2004/098585 Priority application(s): WO2004/098585

11 February 2010 Application Accepted

Published as AU-B-2004237401

10 June 2010 Standard Patent Sealed

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.